{
  "ticker": "EW",
  "last_updated": "2025-04-15T11:21:41.933799",
  "retention_years": 3,
  "count": 51,
  "transactions": [
    {
      "id": 2297,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-07-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 2279,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-07-08",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103056.2782"
    },
    {
      "id": 2298,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-07-08",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 2303,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-07-07",
      "transaction_shares": "2032.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35374.4980"
    },
    {
      "id": 2317,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-07-07",
      "transaction_shares": "6100.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "168874.8696"
    },
    {
      "id": 2290,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-07-05",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209473.8049"
    },
    {
      "id": 2294,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-06-14",
      "transaction_shares": "4809.0000",
      "transaction_price": "87.7500",
      "transaction_type": "S",
      "shares_after_transaction": "26007.7011"
    },
    {
      "id": 2309,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-06-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "186727.8200"
    },
    {
      "id": 2313,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-06-14",
      "transaction_shares": "3675.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "103011.8018"
    },
    {
      "id": 2278,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-06-13",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69285.7842"
    },
    {
      "id": 2296,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-06-01",
      "transaction_shares": "7242.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "209441.0338"
    },
    {
      "id": 2288,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-31",
      "transaction_shares": "9000.0000",
      "transaction_price": "100.8321",
      "transaction_type": "S",
      "shares_after_transaction": "30816.0000"
    },
    {
      "id": 2301,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-26",
      "transaction_shares": "1000.0000",
      "transaction_price": "98.3118",
      "transaction_type": "S",
      "shares_after_transaction": "19911.0000"
    },
    {
      "id": 2268,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-24",
      "transaction_shares": "4809.0000",
      "transaction_price": "95.5200",
      "transaction_type": "S",
      "shares_after_transaction": "39816.0000"
    },
    {
      "id": 2274,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1953.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "29261.0000"
    },
    {
      "id": 2275,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1644.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "20911.0000"
    },
    {
      "id": 2283,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1816.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "204253.0338"
    },
    {
      "id": 2284,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1711.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "44625.0000"
    },
    {
      "id": 2291,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-17",
      "transaction_shares": "211.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "11436.4609"
    },
    {
      "id": 2292,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1743.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "62560.7842"
    },
    {
      "id": 2304,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-17",
      "transaction_shares": "963.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "99336.8018"
    },
    {
      "id": 2306,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-17",
      "transaction_shares": "1730.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "33303.6569"
    },
    {
      "id": 2314,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-17",
      "transaction_shares": "143.0000",
      "transaction_price": "95.9300",
      "transaction_type": "F",
      "shares_after_transaction": "162756.3402"
    },
    {
      "id": 2276,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-08",
      "transaction_shares": "56831.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "157352.8200"
    },
    {
      "id": 2270,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-07",
      "transaction_shares": "595.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "30255.6569"
    },
    {
      "id": 2271,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-07",
      "transaction_shares": "363.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "97553.8018"
    },
    {
      "id": 2273,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "51.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "154983.3402"
    },
    {
      "id": 2282,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-07",
      "transaction_shares": "679.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "200820.0338"
    },
    {
      "id": 2286,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2022-05-07",
      "transaction_shares": "772.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "25111.0000"
    },
    {
      "id": 2300,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-07",
      "transaction_shares": "305.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "18493.0000"
    },
    {
      "id": 2302,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-07",
      "transaction_shares": "604.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "59315.7842"
    },
    {
      "id": 2311,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "11802.4609"
    },
    {
      "id": 2315,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-07",
      "transaction_shares": "633.0000",
      "transaction_price": "100.5200",
      "transaction_type": "F",
      "shares_after_transaction": "40573.0000"
    },
    {
      "id": 2269,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "51880.0000"
    },
    {
      "id": 2272,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 2281,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "WANG HUIMIN",
      "reporting_owner_cik": "0001204553",
      "reporting_owner_position": "CVP, Japan & Intercontinental",
      "transaction_date": "2022-05-04",
      "transaction_shares": "307.0000",
      "transaction_price": "105.9300",
      "transaction_type": "F",
      "shares_after_transaction": "97916.8018"
    },
    {
      "id": 2285,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "66111.0000"
    },
    {
      "id": 2287,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "29077.0000"
    },
    {
      "id": 2293,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "4915.0000"
    },
    {
      "id": 2310,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2300.0000"
    },
    {
      "id": 2318,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2022-05-04",
      "transaction_shares": "2300.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27480.0000"
    },
    {
      "id": 2267,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "60415.7842"
    },
    {
      "id": 2277,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, Surgical Structural Heart",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "19077.0000"
    },
    {
      "id": 2280,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-05-03",
      "transaction_shares": "21250.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "100521.8200"
    },
    {
      "id": 2295,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4150.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "41576.0000"
    },
    {
      "id": 2305,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2022-05-03",
      "transaction_shares": "1180.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "12052.4609"
    },
    {
      "id": 2308,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2022-05-03",
      "transaction_shares": "4425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "202066.0338"
    },
    {
      "id": 2312,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEA, Canada, Latin Amer",
      "transaction_date": "2022-05-03",
      "transaction_shares": "2750.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "155076.3402"
    },
    {
      "id": 2316,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2022-05-03",
      "transaction_shares": "3775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31343.6569"
    },
    {
      "id": 2307,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2022-04-29",
      "transaction_shares": "45050.0000",
      "transaction_price": "21.7600",
      "transaction_type": "M",
      "shares_after_transaction": "124321.8200"
    },
    {
      "id": 2289,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2022-04-28",
      "transaction_shares": "28722.0000",
      "transaction_price": "25.9883",
      "transaction_type": "M",
      "shares_after_transaction": "55499.0000"
    }
  ]
}